|Articles|May 1, 2019

Comprehensive, Automated Cell Culture Analyzer

BioProfile® FLEX2 provides comprehensive analysis of 16 key cell culture parameters including chemistries, gases, osmolality, total and viable cell density and viability.

Nova Biomedical is a technology company based in Waltham, Massachusetts that provides automated cell culture analyzers for pharmaceutical and biotech markets.

 

Products and Services

BioProfile® FLEX2 provides comprehensive analysis of 16 key cell culture parameters including chemistries, gases, osmolality, total and viable cell density and viability. Test menu consists of Gluc, Lac, Gln, Glu, NH4+, Na+, K+, Ca++, pH, pCO2, pO2, Osmolality by freezing point depression, and Total and Viable Cell Density and Viability by trypan blue dye exclusion method. With the addition of the BioProfile External Sampling Module (ESM), FLEX2 is capable of automatic sampling from Sartorius ambr® 15 cell culture systems.

 

Nova Biomedical
200 Prospect St., Waltham, MA 02453
info@novabio.com
tel. 781.894.0800


Related to this article

The BioPharm Brief: A $7 Billion Oncology Option Deal, a TL1A Pivot, and Oral Adalimumab Heads to the Clinic
Boehringer Ingelheim licenses six preclinical ADC and T-cell engager programs from Sino Biopharmaceutical in a deal worth up to $7 billion, Spyre Therapeutics drops anti-TL1A antibody SPY072 in rheumatic diseases after phase 2 misses and turns to hidradenitis suppurativa, and Biora Therapeutics gets ethics approval for a first-in-human trial of its BioJet oral adalimumab capsule.
The Promise of Microgravity for R&D and Manufacturing
As access to low Earth orbit expands, space-based research is opening possibilities in drug discovery, formulation, and manufacturing. In Part 1, the authors look at how microgravity changes biology and chemistry in ways that can’t be reproduced on Earth and where it fits from target discovery to life cycle management.